621 related articles for article (PubMed ID: 12244143)
1. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).
Robbins MA; Maksumova L; Pocock E; Chantler JK
Endocrinology; 2003 Oct; 144(10):4616-25. PubMed ID: 12960048
[TBL] [Abstract][Full Text] [Related]
4. Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias.
Poggi A; Pellegatta F; Leone BE; Moretta L; Zocchi MR
Eur J Immunol; 2000 Oct; 30(10):2751-8. PubMed ID: 11069054
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas.
Jayasooriya RGPT; Moon DO; Park SR; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY
Environ Toxicol Pharmacol; 2013 Sep; 36(2):303-310. PubMed ID: 23708311
[TBL] [Abstract][Full Text] [Related]
7. NF-κB regulates caspase-4 expression and sensitizes neuroblastoma cells to Fas-induced apoptosis.
Yang HJ; Wang M; Wang L; Cheng BF; Lin XY; Feng ZW
PLoS One; 2015; 10(2):e0117953. PubMed ID: 25695505
[TBL] [Abstract][Full Text] [Related]
8. NF-kappa B is required for surface Ig-induced Fas resistance in B cells.
Schram BR; Rothstein TL
J Immunol; 2003 Mar; 170(6):3118-24. PubMed ID: 12626568
[TBL] [Abstract][Full Text] [Related]
9. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.
Osawa Y; Banno Y; Nagaki M; Brenner DA; Naiki T; Nozawa Y; Nakashima S; Moriwaki H
J Immunol; 2001 Jul; 167(1):173-80. PubMed ID: 11418646
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
[TBL] [Abstract][Full Text] [Related]
12. Suppressors of cytokine signaling promote Fas-induced apoptosis through downregulation of NF-κB and mitochondrial Bfl-1 in leukemic T cells.
Oh J; Kim SH; Ahn S; Lee CE
J Immunol; 2012 Dec; 189(12):5561-71. PubMed ID: 23152563
[TBL] [Abstract][Full Text] [Related]
13. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
14. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-kappaB mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL.
Peng Y; Gallagher SF; Haines K; Baksh K; Murr MM
J Surg Res; 2006 Jan; 130(1):58-65. PubMed ID: 16154149
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
[TBL] [Abstract][Full Text] [Related]
17. The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells.
Franco AV; Zhang XD; Van Berkel E; Sanders JE; Zhang XY; Thomas WD; Nguyen T; Hersey P
J Immunol; 2001 May; 166(9):5337-45. PubMed ID: 11313369
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells.
Obara H; Takayanagi A; Hirahashi J; Tanaka K; Wakabayashi G; Matsumoto K; Shimazu M; Shimizu N; Kitajima M
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2198-204. PubMed ID: 11031204
[TBL] [Abstract][Full Text] [Related]
19. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
20. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
